Infertility Treatment Devices and Equipment Market Size & Growth Forecast 2026–2035, By Segments (End-use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Infertility Treatment Devices and Equipment Market size was estimated at USD 323.63 Million in 2025 and is projected to grow at a 10.4% CAGR from 2026 to 2035, reaching USD 870.44 Million by 2035. The industry revenue for 2026 is assessed at USD 353.63 million.

• Base Year Value (2025): USD 323.63 Million
• CAGR (2026-2035): 10.4%
• Forecast Year Value (2035): USD 870.44 Million
• Historical Data Period: 2022-2025
• Largest Region: Europe
• Forecast Period: 2026-2035

Infertility Treatment Devices and Equipment Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Europe held a 42.19% share in 2025, supported by established fertility care infrastructure, widespread use of assisted reproductive technologies, and strong adoption of advanced clinical equipment.
  • Asia Pacific is projected to grow at an 11.65% CAGR as fertility clinics expand, reproductive care investment rises, and providers adopt modern technologies to meet increasing treatment demand.

• Segment Momentum:

  • Fertility Clinics held a 79.12% share in 2025 as they provide specialized reproductive procedures, advanced laboratory infrastructure, and comprehensive treatment workflows requiring dedicated fertility equipment.
  • Imaging Systems are expanding fastest because clinics increasingly invest in technologies that improve procedural precision, treatment monitoring, and clinical decision-making during assisted reproduction procedures.

• Market Expansion Drivers:

  • Rising infertility prevalence driving increased adoption of ART procedures globally.
  • Delayed pregnancies and lifestyle factors increasing demand for fertility interventions.
  • Expansion of IVF clinics and automation in fertility laboratory systems.

• Leading Market Participants:

  Key players in the infertility treatment devices and equipment market include The Cooper Companies, Inc. (United States), Cook Medical LLC (United States), Vitrolife AB (Sweden), Hamilton Thorne Ltd. (Canada), Eppendorf SE (Germany), Rocket Medical plc (United Kingdom), Esco Lifesciences Group Ltd. (Singapore), FUJIFILM Irvine Scientific, Inc. (United States), Genea Biomedx Pty Ltd. (Australia), Nidacon International AB (Sweden).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 323.63 Million
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 870.44 Million by 2035
  • Growth Forecasts: 10.4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: Europe
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Fertility Clinics (End-use) | Sperm Separation Device (Type)
  • Emerging Opportunity Segment: Fertility Clinics (End-use) | Imaging System (Type)

Market Growth Drivers and Industry Trends

Rising infertility prevalence driving increased adoption of ART procedures globally

As infertility affects a larger share of couples and individuals seeking conception, treatment pathways increasingly shift from basic medical management toward assisted reproductive technologies, creating direct equipment demand for ovarian stimulation monitoring, gamete handling, embryo culture, cryopreservation, and micromanipulation. In the infertility treatment devices and equipment market, this pattern strengthens purchasing activity from fertility centers that need to expand procedural capacity, standardize laboratory workflows, and improve cycle efficiency as ART volumes rise. The effect is especially pronounced in clinics prioritizing higher throughput and consistent lab performance, since more patients entering ART programs translates into broader utilization of incubators, imaging systems, sperm processing equipment, and related consumables-supporting instruments.

Delayed pregnancies and lifestyle factors increasing demand for fertility interventions

The growing tendency to postpone childbearing raises the probability that patients enter fertility care at ages when natural conception is less reliable, while lifestyle-related factors such as stress, obesity, and other health conditions increase the likelihood of clinical intervention rather than watchful waiting. This changes demand patterns in the infertility treatment devices and equipment market by bringing more patients into diagnostic workups and medically assisted conception earlier in their treatment journey, prompting clinics to invest in equipment that supports repeated monitoring, egg retrieval, embryo assessment, and preservation strategies. As treatment plans become more intervention-intensive, providers place greater emphasis on technologies that help optimize lab precision and patient cycle management, reinforcing market demand through higher procedural complexity rather than volume alone.

Expansion of IVF clinics and automation in fertility laboratory systems

The expansion of IVF clinic networks is increasing procurement of complete laboratory setups, while automation is changing how providers evaluate capacity, staffing, and consistency in embryo handling and culture processes. In the infertility treatment devices and equipment market, new facility launches and laboratory upgrades translate into demand for integrated workstations, time-lapse imaging, controlled incubator systems, cryostorage equipment, and workflow tools designed to reduce manual variation. Automation also influences buying decisions at established centers, where pressure to improve reproducibility, documentation, and technician efficiency is supporting market expansion through replacement cycles and higher-value system adoption rather than simple unit growth.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising Infertility Prevalence	4.00%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	Medium	Fast
Technological Advancements in Treatment Devices	3.00%	Medium term (2–5 yrs)	Europe, North America (spillover: Asia Pacific)	Low	Moderate
Regulatory Approvals & Insurance Coverage	2.50%	Long term (5+ yrs)	North America, Europe (spillover: MEA)	High	Moderate
Rising infertility prevalence driving increased adoption of ART procedures globally	2.40%	High	North America, Europe, Asia Pacific	High	Near Term
Delayed pregnancies and lifestyle factors increasing demand for fertility interventions	1.90%	High	Global	High	Near Term
Expansion of IVF clinics and automation in fertility laboratory systems	1.60%	High	Asia Pacific, North America	Medium	Mid Term

Regional Demand Dynamics

Europe (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Europe held a 42.19% share of the infertility treatment devices and equipment market in 2025, backed by its established fertility care infrastructure, broad availability of specialized clinics, and consistent use of advanced assisted reproductive technologies in routine clinical practice. The region’s leadership is reinforced by mature treatment pathways, where hospitals and fertility centers are equipped to adopt precision imaging systems, laboratory instruments, and procedural devices as part of standardized infertility care delivery. This operating environment sustains device utilization across diagnosis, egg retrieval, embryo handling, and related treatment workflows, helping Europe maintain the largest regional position.

Asia Pacific is projected to expand at an 11.65% CAGR over the forecast period in the infertility treatment devices and equipment market, driven by rising treatment uptake as fertility services become more accessible across major urban healthcare networks. Growth is being accelerated by the expansion of fertility clinics, increasing investment in reproductive care capabilities, and stronger adoption of modern treatment technologies in countries where patient volumes are climbing. In practice, this is translating into higher demand for core clinical and laboratory equipment as providers scale capacity to manage a growing number of infertility evaluations and assisted reproduction procedures.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Developing
Cost-Sensitive Region	Low	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Supportive	Neutral	Neutral
Demand Drivers	Strong	Strong	Strong	Moderate	Moderate
Development Stage	Developed	Developing	Developed	Developing	Emerging
Adoption Rate	High	High	High	Medium	Medium
New Entrants / Startups	Moderate	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Strong	Stable	Stable	Stable

Key Country Insights

United States

Advanced fertility clinic adoption

In the United States, infertility treatment devices and equipment adoption is driven by advanced fertility clinic networks and high utilization of assisted reproductive technologies. The market reflects strong integration of automated laboratory systems, embryo culture technologies, and precision diagnostics, with clinics continuously upgrading infrastructure to improve procedural success and workflow efficiency.

Japan

Minimally invasive reproductive tech

In Japan, infertility treatment devices and equipment usage is shaped by preference for minimally invasive reproductive technologies and careful clinical practices. The market emphasizes advanced diagnostic precision, embryo handling systems, and controlled laboratory environments, with healthcare providers focusing on improving patient outcomes while maintaining strict procedural safety standards.

South Korea

High-tech fertility solutions

In South Korea, infertility treatment devices and equipment demand is driven by advanced reproductive medicine centers and strong adoption of high-tech fertility solutions. The market reflects integration of digital monitoring systems, sophisticated IVF technologies, and continuous innovation in clinical workflows to support personalized and efficient fertility treatment services.

Germany

Clinical protocol-driven usage

In Germany, infertility treatment devices and equipment are adopted within highly protocol-driven clinical environments emphasizing safety, standardization, and precision. The market is characterized by strong hospital-based fertility services, structured treatment pathways, and consistent investment in laboratory-grade equipment aligned with stringent medical regulatory frameworks and quality assurance requirements.

France

Public-private fertility care balance

In France, infertility treatment devices and equipment adoption is influenced by a balanced public-private healthcare system, where access to assisted reproductive technologies is expanding through regulated clinical frameworks. The market reflects steady investment in modern fertility laboratories and standardized treatment infrastructure within both hospital networks and private clinics.

Italy

Specialist clinic driven demand

In Italy, infertility treatment devices and equipment demand is concentrated in specialist fertility clinics and private healthcare providers. The market reflects gradual modernization of assisted reproduction infrastructure, with increasing adoption of advanced laboratory systems and diagnostic tools to support improving patient access and treatment outcomes.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Fertility Clinics (Largest & Fastest-Growing Segment)

Fertility clinics held a 79.12% share of the infertility treatment devices and equipment market in 2025, reflecting their central role in delivering assisted reproductive procedures that require specialized instruments, controlled lab environments, and trained clinical teams. This end-use segment continues to expand the fastest because fertility clinics concentrate the full treatment workflow in one setting, making them the most practical destination for patients seeking diagnosis, embryo handling, insemination support, and related interventions. Their leadership and ongoing growth in the infertility treatment devices and equipment market are sustained by the direct alignment between advanced reproductive equipment and clinic-based care, where utilization rates, procedural volume, and the need for dedicated treatment infrastructure remain highest.

Type Segment Analysis: Sperm Separation Device (Largest Segment) vs Imaging System (Fastest-Growing Segment)

Within the infertility treatment devices and equipment market, sperm separation devices accounted for a 19.43% share in 2025, making them the leading type segment due to their routine use in core fertility treatment workflows. Their market leadership is underpinned by the fact that sperm preparation is a fundamental step across a broad range of assisted reproduction procedures, which keeps demand steady across fertility care settings. Because these devices are tied closely to everyday laboratory processing rather than selective or occasional use, they retain a larger installed and replacement base in the market.

Imaging systems are emerging as the fastest-growing type segment in the infertility treatment devices and equipment market as fertility providers place greater emphasis on procedural precision and closer visual assessment during treatment. Growth is being underpinned by the practical need to improve monitoring and decision-making during reproductive procedures, which makes imaging capability increasingly valuable relative to more established equipment categories. As clinics invest in technologies that strengthen treatment accuracy and workflow confidence, imaging systems are gaining momentum faster than alternatives that are already more deeply penetrated in routine lab processes.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Fertility Clinics, Hospitals & Other Healthcare Facilities, Clinical Research Institutes	Fertility Clinics	Fertility Clinics
Type	Ovum Aspiration Pumps, Sperm Separation Device, Sperm Analyzer Systems, Micromanipulators Systems, Incubators, Cryosystems, Imaging System, Microscopes, Others	Sperm Separation Device	Imaging System

Competitive Landscape and Market Positioning

Top players in the infertility treatment devices and equipment market:

1. The Cooper Companies Inc. (United States)

2. Cook Medical LLC (United States)

3. Vitrolife AB (Sweden)

4. Hamilton Thorne Ltd. (Canada)

5. Eppendorf SE (Germany)

6. Rocket Medical plc (United Kingdom)

7. Esco Lifesciences Group Ltd. (Singapore)

8. FUJIFILM Irvine Scientific Inc. (United States)

9. Genea Biomedx Pty Ltd. (Australia)

10. Nidacon International AB (Sweden)

The infertility treatment devices and equipment market is advancing through improved precision tools and assisted reproductive technologies. Enhanced laboratory systems and automation are improving treatment success rates. Collaborative development efforts are expanding technological capabilities across fertility solutions. Continuous innovation in device design and functionality is strengthening clinical efficiency, driving the infertility treatment devices and equipment market toward more effective reproductive healthcare solutions.

Industry Development/News

Company Name	Date	Key Development
Columbia University Fertility Center	Jun-25	Columbia University Fertility Center reported the first pregnancy achieved using the STAR AI system, enabling conception in an azoospermic patient after 18 years of infertility. The development highlights clinical validation of AI-enabled sperm identification technology, marking a notable advancement in assisted reproductive technologies and infertility treatment workflows.
U.S. Food and Drug Administration (FDA)	May-25	The U.S. FDA classified anti-mullerian hormone test systems as Class II devices with special controls, clarifying regulatory requirements for ovarian reserve diagnostics. This decision standardizes compliance pathways for manufacturers and supports broader commercialization of infertility-related hormonal testing technologies.
Overture Life	Apr-25	Overture Life raised USD 20.6 million, bringing total funding to USD 57 million, to accelerate deployment of IVF automation technologies. The financing supports scaling of automated laboratory solutions aimed at improving efficiency, consistency, and throughput in assisted reproductive treatment workflows.
Conceivable Life Sciences	Jan-25	Conceivable Life Sciences secured USD 18 million in Series A funding led by ARTIS Ventures to develop and commercialize an AI-powered automated IVF laboratory. The investment supports advancement of end-to-end automation in fertility treatment processes, targeting improved scalability and operational efficiency in IVF clinics.